earticle

Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-re sistant subtype with distinct molecular features

Won Suk Lee, Seonjeong Woo, Sung Hwan Lee, Gae Hoon Jo, Ilhwan Kim, Hyeyeong Kim, Chansik An, Sanghoon Jung, Gwangil Kim, Haeyoun Kang, Beodeul Kang, Jung Sun Kim, Ho Yeong Lim, Incheon Kang, Hannah Yang, So Jung Kong, Dahyeon Son, Dong Jun Shin, Woo Young Kwon, Da-Yeon Lee, Ju-Seog Lee, Junho Park, Youngsoo Kim, Sohyun Hwang, Chan Kim, Hong Jae Chon

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.32 No.1 2026.01 pp.258-275

Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ [Clin Mol Hepatol 2024;30:807-823]

Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ju-Seog Lee

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.31 No.2 2025.04 pp.669-670

Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”

Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Peng Wei, Ju-Seog Lee

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.31 No.1 2025.01 pp.110-112

Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”

Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju-Seog Lee

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.31 No.1 2025.01 pp.81-83

Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”

Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju-Seog Lee

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.31 No.1 2025.01 pp.84-86

Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial

Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, 강상희, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, 박영년, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.30 No.4 2024.10 pp.807-823

Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B

Jae-Jun Shim, In Hwan Oh, Sang Bae Kim, 김정욱, 이창균, 장재영, Ju-Seog Lee, Byung-Ho Kim

[NRF 연계] 거트앤리버 소화기연관학회협의회 Gut and Liver Vol.10 No.6 2016.11 pp.962-968

Systems Biology Approaches to Decoding the Genome of Liver Cancer

Ju-Seog Lee, Ji Hoon Kim, Yun-Yong Park, Gordon B. Mills

[NRF 연계] 대한암학회 CANCER RESEARCH AND TREATMENT Vol.43 No.4 2011.12 pp.205-211